Osaic Holdings’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

Osaic Holdings’s Portfolio MITO Stock Details MITO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,124	Closed	-$3K	–	7707
2022 Q3	$3K	Buy	10,124 +469	+5%	+$133	﹤0.01%	6716
2022 Q2	$2K	Buy	9,655 +3,116	+48%	+$1.07K	﹤0.01%	6993
2022 Q1	$5K	Buy	6,539 +1,482	+29%	+$1K	﹤0.01%	6550
2021 Q4	$4K	Buy	5,057 +2,314	+84%	+$2.41K	﹤0.01%	6830
2021 Q3	$4K	Buy	2,743 +474	+21%	+$643	﹤0.01%	6689
2021 Q2	$4K	Buy	2,269 +859	+61%	+$1.2K	﹤0.01%	6542
2021 Q1	$2K	Buy	1,410 +576	+69%	+$990	﹤0.01%	6558
2020 Q4	$1K	Buy	834 +230	+38%	+$323	﹤0.01%	6329
2020 Q3	$1K	Buy	+604	New	+$1.03K	﹤0.01%	6129

Osaic Holdings's MITO Position: Q4 2022 in Review

Osaic Holdings sold out of Stealth BioTherapeutics Corp. ADS (MITO) in Q4 2022, closing a stake of 10,124 shares — an estimated $3K sold.

Osaic Holdings first reported a position in MITO in Q3 2020 and held it in 9 quarters. The position peaked at $5K in Q1 2022. 0 funds tracked by Wall St. Rank hold MITO as of Q4 2022.

Osaic Holdings reported no remaining Stealth BioTherapeutics Corp. ADS position as of Q4 2022 after selling out during the quarter.
Osaic Holdings sold 10,124 Stealth BioTherapeutics Corp. ADS shares in Q4 2022, an estimated $3K.
Osaic Holdings first reported a position in Stealth BioTherapeutics Corp. ADS in Q3 2020 and held it in 9 quarters.
Osaic Holdings's Stealth BioTherapeutics Corp. ADS position peaked at $5K in Q1 2022.
0 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q4 2022.

Based on Osaic Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.